Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Vascular Solutions LLC VASC NASDAQ

NASDAQ • Healthcare • Medical - Devices • USD

SharesGrow Score
63/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Vascular Solutions LLC (VASC) is a Medical - Devices company in the Healthcare sector, currently trading at $56.00. It has a SharesGrow Score of 61/100, indicating a above average investment profile with 3 out of 7 criteria passed.

Financials: revenue is $147M, +14.4%/yr average growth. Net income is $10M, growing at +3%/yr. Net profit margin is 7.1% (thin). Gross margin is 66.8% (-0.1 pp trend).

Balance sheet: total debt is $4M against $128M equity (Debt-to-Equity (D/E) ratio 0.03, conservative). Current ratio is 5.23 (strong liquidity). Debt-to-assets is 2.5%. Total assets: $145M.

SharesGrow 7-Criteria breakdown: Value 15/100 (Fail), Growth 63/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 54/100 (Partial), Future ?/100 (Fail), Income 45/100 (Partial).

VASC SharesGrow Score Overview

63/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 15/100
Valuation — P/E, PEG, Forward PEG
GROWTH 63/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 54/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 45/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — VASC

✗
VALUE Fail
15/100
VASC trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
✓
GROWTH Pass
63/100
VASC: +14.4%/yr revenue is, +3%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✓
PAST Pass
100/100
VASC: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
✓
HEALTH Pass
100/100
Balance sheet VASC: Debt-to-Equity (D/E) ratio 0.03 (conservative), Current ratio is 5.23 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
54/100
VASC: Gross margin is 66.8% (-0.1 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 54/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
~
INCOME Partial
45/100
VASC: Net profit margin is 7.1%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range57.15-25.06
Volume1.21M
Avg Volume (30D)157.96K
Beta (1Y)1.06
Share Statistics
EPS (TTM)0.61
Shares Outstanding$17.1M
IPO Date2000-07-20
Financial Highlights & Ratios
Revenue (TTM)$147.2M
Gross Profit$98.3M
EBITDA$19.64M
Net Income$10.46M
Operating Income$13.6M
Total Cash$41.49M
Total Debt$3.63M
Net Debt$-37.87M
Total Assets$144.87M
Price / Earnings (P/E)91.8
Analyst Forecast
Company Info
ExchangeNASDAQ
CurrencyUSD

Price Chart

Track all markets on TradingView
VASC
Vascular Solutions LLC  ·  NASDAQ
Healthcare • Medical - Devices

People Also View

LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
 RHHBF
RHHBF
Roche Holding AG
$418.50
+1.82%
 RHHBY
RHHBY
Roche Holding AG
$51.02
+0.65%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 NVSEF
NVSEF
Novartis AG
$156.48
+0.00%
 MRK
MRK
Merck & Co., Inc.
$119.96
-0.16%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message